- Home
- ADT vs CORT Comparison
ADT vs CORT Comparison
Compare ADT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADT
- CORT
- Stock Information
- Founded
- ADT 1874
- CORT 1998
- Country
- ADT United States
- CORT United States
- Employees
- ADT N/A
- CORT N/A
- Industry
- ADT Diversified Commercial Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- ADT Consumer Discretionary
- CORT Health Care
- Exchange
- ADT Nasdaq
- CORT Nasdaq
- Market Cap
- ADT 6.3B
- CORT 7.1B
- IPO Year
- ADT 2018
- CORT N/A
- Fundamental
- Price
- ADT $7.35
- CORT $63.54
- Analyst Decision
- ADT Hold
- CORT Strong Buy
- Analyst Count
- ADT 4
- CORT 4
- Target Price
- ADT $8.55
- CORT $97.00
- AVG Volume (30 Days)
- ADT 6.2M
- CORT 894.6K
- Earning Date
- ADT 02-27-2025
- CORT 02-26-2025
- Dividend Yield
- ADT 3.00%
- CORT N/A
- EPS Growth
- ADT 2041.84
- CORT 57.97
- EPS
- ADT 0.98
- CORT 1.26
- Revenue
- ADT $5,140,300,000.00
- CORT $628,555,000.00
- Revenue This Year
- ADT N/A
- CORT $46.47
- Revenue Next Year
- ADT $4.36
- CORT $21.49
- P/E Ratio
- ADT $7.51
- CORT $50.40
- Revenue Growth
- ADT 7.14
- CORT 39.67
- 52 Week Low
- ADT $6.10
- CORT $20.84
- 52 Week High
- ADT $8.25
- CORT $75.00
- Technical
- Relative Strength Index (RSI)
- ADT 46.77
- CORT 46.90
- Support Level
- ADT $7.36
- CORT $71.50
- Resistance Level
- ADT $7.67
- CORT $75.00
- Average True Range (ATR)
- ADT 0.18
- CORT 3.33
- MACD
- ADT -0.03
- CORT -0.74
- Stochastic Oscillator
- ADT 9.71
- CORT 3.00
About ADT ADT Inc.
ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. It offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. The company segments include Consumer and Small Business (CSB), Commercial, and Solar. It generates maximum revenue from the Commercial segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.